| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/15/2003 | US6593342 Pharmaceutical compositions comprising 2-quinolones |
| 07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
| 07/15/2003 | US6593332 Phosphodiesterase inhibitors; sexual disorders |
| 07/15/2003 | US6593330 Compounds and their use |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6592633 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 07/15/2003 | CA2180843C Pyridine modulators of acetylcholine receptors |
| 07/15/2003 | CA2128601C Quinolone carboxylic acid derivatives in crystalline hydrate form |
| 07/10/2003 | WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 07/10/2003 | WO2003055875A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/10/2003 | WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/10/2003 | WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003055865A1 Quinazolinone derivative |
| 07/10/2003 | WO2003055863A1 Novel alkansulfonamides as endothelin antagonists |
| 07/10/2003 | WO2003055860A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055522A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/10/2003 | WO2003055491A1 Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 07/10/2003 | WO2003043987A3 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/10/2003 | WO2003022274A3 2-aroylimidazole compounds for treating cancer |
| 07/10/2003 | WO2003021355A9 Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 07/10/2003 | WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130520 Producing substituted 2-nitro-guanidine derivatives. |
| 07/10/2003 | US20030130516 E.g., reacting a 6H-imidazo(4,5-c) tetrazolo(1,5-a)quinoline with triphenylphosphine and hydrolyzing the product thereof. |
| 07/10/2003 | US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis. |
| 07/10/2003 | US20030130506 4-phenoxy or 4-(pyrid-4-yloxy)- benzensulfonic acid derivatives; antitumor and antiarthritic agents |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130384 Flame retardant compositions |
| 07/10/2003 | US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride |
| 07/10/2003 | US20030130319 Aminopyrrole compounds |
| 07/10/2003 | US20030130309 Antiinflammatory agents; rheumatic diseases |
| 07/10/2003 | US20030130302 Bactericides |
| 07/10/2003 | US20030130289 Inhibitors of glycogen synthase kinase 3 |
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2003 | US20030130281 DPP IV inhibitors |
| 07/10/2003 | US20030130280 Analyzing, prevention blood phosphorylation |
| 07/10/2003 | US20030130275 Sulfonamide compounds with pharmaceutical activity |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130270 Heterocyclic derivatives and their use as antithrombotic agents |
| 07/10/2003 | US20030130265 Benzimidazole derivatives, a process for their manufacture and use as a medicine |
| 07/10/2003 | US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders |
| 07/10/2003 | US20030130260 Aryl fused azapolycyclic compounds |
| 07/10/2003 | US20030130259 Quinoline and quinazoline compounds useful in therapy |
| 07/10/2003 | US20030130257 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130256 Stimulant of central nervous system regeneration |
| 07/10/2003 | US20030130253 Central nervous system disorders; skin disorders; appetite suppressants |
| 07/10/2003 | US20030130251 Blocking amyloid deposits; Alzheimer's disease, Down syndrome |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors |
| 07/10/2003 | US20030130234 Novel indolinones and uses thereof |
| 07/10/2003 | US20030130125 Pesticides; herbicides |
| 07/10/2003 | US20030129552 Color photothermography |
| 07/10/2003 | US20030127129 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/09/2003 | EP1325921A2 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators |
| 07/09/2003 | EP1325914A1 Tetrahydroquinoline compounds |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1325085A1 Cationic imidazole azo dyes |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 07/09/2003 | EP1324741A1 Method of dyeing keratin-containing fibres |
| 07/09/2003 | EP1165496B1 Substituted aniline compounds |
| 07/09/2003 | EP1072588B1 Process for producing arylsulfenyl halide |
| 07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 07/09/2003 | EP0912557B1 Oxindole derivatives |
| 07/09/2003 | EP0906292B1 Triazolyl mercaptides and their use as microbicides |
| 07/09/2003 | EP0900208B1 Acyl mercapto-triazolyl derivatives and the use thereof as microbicides |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | CN1429231A Ligand and complex for catalytically bleaching substate |
| 07/09/2003 | CN1429229A Hydroxylamine esters as polymerization initiators |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1429126A Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 07/09/2003 | CN1113879C Method for synthesis of benzimidazole compound |
| 07/09/2003 | CN1113652C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignant tumour |
| 07/08/2003 | US6590103 Reacting 2,5-dibromopyridine with isopropylmagnesium chloride and methanesulfonyl chloride, then with hydrazine hydrate to form 2-hydrazino-5-(methanesulfonyl)-pyridine, used as intermediates for pyridyl-pyrazoles; antiinflammtory agents |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589963 Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin |
| 07/08/2003 | US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist. |
| 07/08/2003 | US6589955 Pediatric formulation of gatifloxacin |
| 07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
| 07/08/2003 | US6589953 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 07/08/2003 | US6589951 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/07/2003 | CA2415591A1 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/03/2003 | WO2003054073A1 Novel flame retarding compounds |
| 07/03/2003 | WO2003053959A1 Heterocyclylamino carbonyluracils |
| 07/03/2003 | WO2003053956A1 Piperidine-2,6-diones that are heterocyclically substituted in position 3 |
| 07/03/2003 | WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases |